HRB National Drugs LIbrary e-newsletter: volume 14, issue 7

In this issue

Evidence Resources

Drug and alcohol treatment outcomes: measuring effectiveness.

Public Health England. (2018) Drug and alcohol treatment outcomes: measuring effectiveness. Public Health England.

Families First. An evidence-based approach to protecting UK families from alcohol-related harm.

The Alcohol and Families Alliance. (2018) Families First. An evidence-based approach to protecting UK families from alcohol-related harm. London: The Alcohol and Families Alliance. 30 p.

Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection.

World Health Organization. (2018) Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization. 108 p.

Systematic review on the prevention and control of blood-borne viruses in prison settings.

European Centre for Disease Prevention and Control. (2018) Systematic review on the prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC. 198 p.

Public health guidance on prevention and control of blood-borne viruses in prison settings.

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. (2018) Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA. 68 p.

Impact of Restriction on Bail on offenders who use Class A drugs in Liverpool.

Critchley, Karen and Whitfield, Mark . (2018) Impact of Restriction on Bail on offenders who use Class A drugs in Liverpool. Public Health Institute, Faculty of Education, Health and Community; Liverpool John Moores University. 18 p.

The lost decade: neglect for harm reduction funding and the health crisis among people who use drugs.

Cook, Catherine and Davis, Charlotte [Harm Reduction International] . (2018) The lost decade: neglect for harm reduction funding and the health crisis among people who use drugs. London: Harm Reduction International. 31 p.

Police & harm reduction: how law enforcement can advance public safety, public health, and public confidence.

Krupanski, Marc . (2018) Police & harm reduction: how law enforcement can advance public safety, public health, and public confidence. New York: Open Society Foundations. 32 p.

Methadone maintenance treatment and mortality in people with criminal convictions: a population-based retrospective cohort study from Canada.

Russolillo, Angela and Moniruzzaman, Akm and Somers, Julian M [PLOS One] . (2018) Methadone maintenance treatment and mortality in people with criminal convictions: a population-based retrospective cohort study from Canada. Public Library of Science. PLoS ONE, 15 (7 e1002625) https://doi.org/10.1371/journal.pmed.1002625

Guidelines for ATC classification and DDD assignment 2018.

WHO Collaborating Centre for Drug Statistics Methodology. (2017) Guidelines for ATC classification and DDD assignment 2018. Oslo: WHO Collaborating Centre for Drug Statistics Methodology. 285 p.

Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F) in the framework of the Council Decision on new psychoactive substances. Risk assessments.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F) in the framework of the Council Decision on new psychoactive substances. Risk assessments. Luxembourg: Publications Office of the European Union. 50 p.

Report on the risk assessment of N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) in the framework of the Council Decision on new psychoactive substances. Risk Assessments.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction. 67 p.

Report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB) in the framework of the Council Decision on new psychoactive substances. Risk Assessments.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB) in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: Publications Office of the European Union. 64 p.

Report on the risk assessment of N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4-fluoroisobutyrylfentanyl 4F-iBF), in the framework of the Council Decision on new psychoactive substances. Risk Assessments.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4-fluoroisobutyrylfentanyl 4F-iBF), in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: Publications Office of the European Union. 55 p.

Report on the risk assessment of methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil) in the framework of the Council Decision on new psychoactive substances.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2018) Report on the risk assessment of methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union. 105 p.

Measuring alcohol-related harm; politics and science.

Drug and Alcohol Findings. (2018) Measuring alcohol-related harm; politics and science. London: Drug and Alcohol Findings. Drug and Alcohol Findings Hot Topics 7 p.

Preventing alcohol and tobacco exposed pregnancies: CHOICES Plus in primary care.

Drug and Alcohol Findings. (2018) Preventing alcohol and tobacco exposed pregnancies: CHOICES Plus in primary care. London: Drug and Alcohol Findings. Drug and Alcohol Findings Research Analysis 5 p.

Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USA.

Russell, Christopher and McKeganey, Neil and Dickson, Tiffany and Nides, Mitchell [Biomed Central] . (2018) Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USA. BioMed Central. Harm Reduction Journal, 15 (1)

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.

Campbell, Gabrielle and Hall, Wayne D and Peacock, Amy and Lintzeris, Nicholas and Bruno, Raimondo and Larance, Briony and Nielsen, Suzanne and Cohen, Milton and Chan, Gary and Mattick, Richard P and Blyth, Fiona and Shanahan, Marian and Dobbins, Tim and Farrell, Michael and Degenhardt, Louisa . (2018) Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Elsevier. (7) e341. DOI: https://doi.org/10.1016/S2468-2667(18)30110-5

Fit for purpose? An analysis of the role of the Portman Group in alcohol industry self-regulation.

Alcohol Concern, Alcohol Research UK. (2018) Fit for purpose? An analysis of the role of the Portman Group in alcohol industry self-regulation. London: Alcohol Concern and Alcohol Research UK. 44 p.

Drug Treatment Matrix cell B4: Practitioners - psychosocial therapies

Drug and Alcohol Findings (2018) Drug Treatment Matrix cell B4: Practitioners - psychosocial therapies. London: Drug and Alcohol Findings. 8 p.

Drug Treatment Matrix cell C4: Management/supervision - psychosocial therapies

Drug and Alcohol Findings (2018) Drug Treatment Matrix cell C4: Management/supervision - psychosocial therapies. London: Drug and Alcohol Findings. 2 p.

Drug Treatment Matrix cell D4: Organisational functioning - psychosocial therapies

Drug and Alcohol Findings (2018) Drug Treatment Matrix cell D4: Organisational functioning - psychosocial therapies. London: Drug and Alcohol Findings. 4 p

Drug Treatment Matrix cell E4: Treatment systems - psychosocial therapies.

Drug and Alcohol Findings (2018) Drug Treatment Matrix cell E4: Treatment systems - psychosocial therapies. London: Drug and Alcohol Findings. 6 p

Drug Treatment Matrix cell A5: Interventions - safeguarding the community.

Drug and Alcohol Findings (2018) Drug Treatment Matrix cell A5: Interventions - safeguarding the community. London: Drug and Alcohol Findings. 2 p

Copyright © 2018 HRB National Drugs Library. All rights reserved.

The HRB National Drugs Library newsletter is a free subscriber-only monthly email newsletter offering relevant Irish and international news and information on drug and alcohol research. E-mail addresses provided for the purpose of subscribing to the newsletter will only be used by the library to distribute the requested information. We do not distribute your e-mail address to any third parties. The newsletter is published by the HRB National Drugs Library, Health Research Board. The library is staffed by qualified information professionals who handle a wide range of enquiries daily. Not sure what we can do for you? Phone or email us and we will be happy to discuss your information needs.